Ascendis Pharma Endocrinology Division A/s
Clinical trials sponsored by Ascendis Pharma Endocrinology Division A/s, explained in plain language.
-
Tracking a growth hormone treatment in real life
Disease control Recruiting nowThis study aims to gather long-term information on how effective and safe the growth hormone treatment SKYTROFA is for people with growth hormone deficiency. It will follow 900 patients in the US who are already receiving this medication as part of their normal doctor's care. The…
Sponsor: Ascendis Pharma Endocrinology Division A/S • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Scientists track Long-Term safety of approved growth hormone
Knowledge-focused Recruiting nowThis study aims to monitor the long-term safety of an already approved growth hormone treatment called lonapegsomatropin. It will follow 500 children with growth hormone deficiency in the US and Europe who are already receiving this treatment in real-world settings. The main goal…
Sponsor: Ascendis Pharma Endocrinology Division A/S • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:56 UTC